A phase 1, open-label, dose-escalation and dose-expansion study evaluating the safety, feasability and efficacy of ODI-2001 vaccine, a personalized immunotherapy, in patients with metastatic or locally advanced colon cancer of pancreatic cancer

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 83
• 2 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with colon (colorectal) cancer or pancreatic cancer that has spread or is locally advanced. It tests ODI-2001, a personalized vaccine-type immunotherapy.

Age

18 years or older

Sex

Women and men can join

Disease stage

Metastatic or locally advanced colorectal cancer, or metastatic or locally advanced pancreatic cancer

Read by machine on 9 Nov 2026.

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details